|
|
Volumn 349, Issue 11, 2003, Pages 1015-1016
|
|
Atrial fibrillation and stroke prevention
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACETYLSALICYLIC ACID;
ANTICOAGULANT AGENT;
ANTITHROMBOCYTIC AGENT;
ANTIVITAMIN K;
WARFARIN;
XIMELAGATRAN;
AGE DISTRIBUTION;
ANTICOAGULATION;
BLEEDING;
CARDIOVERSION;
CLINICAL FEATURE;
CLINICAL TRIAL;
DOSE RESPONSE;
DRUG EFFICACY;
EPIDEMIOLOGICAL DATA;
HEART ATRIUM FIBRILLATION;
HEART OUTPUT;
HUMAN;
PRACTICE GUIDELINE;
PREVALENCE;
PRIMARY PREVENTION;
PRIORITY JOURNAL;
REVIEW;
RISK ASSESSMENT;
RISK BENEFIT ANALYSIS;
RISK FACTOR;
SINUS RHYTHM;
STROKE;
TREATMENT INDICATION;
TREATMENT OUTCOME;
AGED;
CEREBROVASCULAR ACCIDENT;
NOTE;
THROMBOEMBOLISM;
AGED;
ANTICOAGULANTS;
ASPIRIN;
ATRIAL FIBRILLATION;
CEREBROVASCULAR ACCIDENT;
HUMANS;
THROMBOEMBOLISM;
WARFARIN;
|
|
EID: 0041886590
PISSN: 00284793
EISSN: None
Source Type: Journal
DOI: 10.1056/NEJMp038123 Document Type: Review |
|
Times cited : (66)
|
|
References (1)
|
